Results 71 to 80 of about 24,218 (173)

Inhibition of Induction of Rat Liver Tyrosine Aminotransferase by d-Galactosamine

Journal of Biological Chemistry, 1973
Abstract 1. An injection of d-galactosamine at the same time as an injection of dexamethasone inhibits the increase of rat liver tyrosine aminotransferase activity normally observed following injection of dexamethasone alone. The galactosamine-mediated inhibition is dose dependent: a 50% inhibition of the increase of enzyme activity is observed at 10 ...
R D, Reynolds, W, Reutter
openaire   +2 more sources

Diosgenyl 2-amino-2-deoxy-β-D-galactopyranoside: synthesis, derivatives and antimicrobial activity

Beilstein Journal of Organic Chemistry, 2017
The synthesis of diosgenyl 2-amino-2-deoxy-β-D-galactopyranoside is presented for the first time. This synthetic saponin was transformed into its hydrochloride as well as N-acyl, 2-ureido, N-alkyl, and N,N-dialkyl derivatives.
Henryk Myszka, Patrycja Sokołowska, Agnieszka Cieślińska, Andrzej Nowacki, Maciej Jaśkiewicz, Wojciech Kamysz, Beata Liberek   +6 more
doaj   +1 more source

Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury

Scientific Reports, 2017
Growing evidence has shown that gut microbiome is a key factor involved in liver health. Therefore, gut microbiota modulation with probiotic bacteria, such as Saccharomyces boulardii, constitutes a promising therapy for hepatosis. In this study, we aimed
Lei Yu, Xue-ke Zhao, Ming-liang Cheng, Guo-zhen Yang, Bi Wang, Hua-juan Liu, Ya-xin Hu, Li-li Zhu, Shuai Zhang, Zi-wen Xiao, Yong-mei Liu, Bao-fang Zhang, Mao Mu   +12 more
doaj   +1 more source

The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury

Mediators of Inflammation, 2017
As the major active ingredient of Cordyceps militaris, cordycepin (3′-deoxyadenosine) has been well documented to alleviate inflammation and oxidative stress both in vitro and in vivo. To explore the potential protective effect of cordycepin in fulminant
Jin Li, Liping Zhong, Haibo Zhu, Fengzhong Wang   +3 more
doaj   +1 more source

Short-term fasting attenuates lipopolysaccharide/D-galactosamine-induced acute liver failure through Sirt1-autophagy signaling in mice. [PDF]

MedComm (2020), 2023
Long B, Tao H, Tong S, Wang X, Yin W.
europepmc   +1 more source

Preventive Effect of 6-shogaol on D-galactosamine Induced Hepatotoxicity Through NF-?B/MAPK Signaling Pathway in Rats. [PDF]

Physiol Res, 2023
Zong X, Ding Q, Liu X, Liu Q, Song S, Yan X, Zhang Y.   +6 more
europepmc   +1 more source

Protective effects of glutamine on lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice. [PDF]

Exp Biol Med (Maywood), 2023
Yang M, Zhang X, Zhao S, Shao R, Fan K, Hu K, Zhang L, Yang Y.   +7 more
europepmc   +1 more source

Deficiency of Ninjurin1 attenuates LPS/D-galactosamine-induced acute liver failure by reducing TNF-α-induced apoptosis in hepatocytes. [PDF]

J Cell Mol Med, 2022
Kim MW, Kang JH, Jung HJ, Park SY, Hwang JI, Seong JK, Yoon YS, Oh SH.   +7 more
europepmc   +1 more source

Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice. [PDF]

J Clin Transl Hepatol, 2022
Wu YL, Ou WJ, Zhong M, Lin S, Zhu YY.
europepmc   +1 more source

Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice. [PDF]

Nutrients, 2023
Yuan C, Fan J, Jiang L, Ye W, Chen Z, Wu W, Huang Q, Qian L.   +7 more
europepmc   +1 more source